Robert Zamboni
Publications by Year
Research Areas
Asthma and respiratory diseases, Chemical Synthesis and Analysis, Inflammatory mediators and NSAID effects, Fluorine in Organic Chemistry, Carbohydrate Chemistry and Synthesis
Most-Cited Works
- → Involvement of Caspases in Proteolytic Cleavage of Alzheimer’s Amyloid-β Precursor Protein and Amyloidogenic Aβ Peptide Formation(1999)785 cited
- → The discovery of odanacatib (MK-0822), a selective inhibitor of cathepsin K(2008)470 cited
- → Etoricoxib (MK-0663): Preclinical Profile and Comparison with Other Agents That Selectively Inhibit Cyclooxygenase-2(2001)457 cited
- → The discovery of rofecoxib, [MK 966, VIOXX®, 4-(4′-methylsulfonylphenyl)-3-phenyl-2(5H)-furanone], an orally active cyclooxygenase-2 inhibitor(1999)427 cited
- → Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX‐2 inhibitor(1997)326 cited
- → Pharmacology of L-660,711 (MK-571): a novel potent and selective leukotriene D4 receptor antagonist(1989)270 cited
- → Purification and catalytic properties of human caspase family members(1999)233 cited
- → Practical Route to a New Class of LTD4 Receptor Antagonists(1996)223 cited
- → Suppression of Rho-kinase activity promotes axonal growth on inhibitory CNS substrates(2003)212 cited
- → Selective, Reversible Caspase-3 Inhibitor Is Neuroprotective and Reveals Distinct Pathways of Cell Death after Neonatal Hypoxic-ischemic Brain Injury(2002)177 cited